You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LYEL Buy Disclosure
Arch Venture Fund Xiii, L.p. · SEC Form 4 · Filed Nov 5, 2026
Buy
Calculated transaction value
$25M
Arch Venture Fund Xiii, L.p. 10% owner
LYEL
Lyell Immunopharma
LYEL
Transaction date
Nov 4, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 1 day later
LYEL daily price context
Close on/before transaction
$15.43
Nov 4, 2026
First close after public filing
$14.86
Nov 6, 2026
Return after filing · so far
+13.46%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,321,262 shares @ $10.77
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001012975-26-001013
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$25M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Buy | Nov 4, 2026 | $25M |